Does highly active antiretroviral therapy improve neurocognitive function? A systematic review John A. JoskaHetta GouseAlan J. Flisher Review Pages: 101 - 114
Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy—treated subjects with human immunodeficiency virus type 1 infection Bing SunLinda AbadjianLynn Pulliam OriginalPaper Pages: 115 - 124
Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus—associated encephalopathy—like changes in neonatal mice Tomohisa TanakaYuji SundenTakashi Umemura OriginalPaper Pages: 125 - 132
Varicella-zoster virus—induced apoptosis in MeWo cells is accompanied by down-regulation of Bcl-2 expression Elizabeth BrazeauRavi MahalingamSubbiah Pugazhenthi OriginalPaper Pages: 133 - 140
Association of autism with polyomavirus infection in postmortem brains Carla LintasLaura AltieriAntonio M. Persico OriginalPaper Pages: 141 - 149
Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent Abdelkader KhiatiOlivier ChaloinPhilippe Horellou OriginalPaper Pages: 150 - 167
Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat Katy M. WebbMichael Y. AksenovRosemarie M. Booze Short Communication Pages: 168 - 173
Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient Ferhat ArslanFehmi TabakBurhan Ferhanoglu Case Report Pages: 174 - 178
Human immunodeficiency virus—associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution Albert M. AndersonJack A. FountainMelody P. Palmore Case Report Pages: 179 - 184
